My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
March 2009
Vol. 19 No. 3
Top Stories
New Influenza Guidelines Released

A new IDSA guideline for seasonal influenza in adults and children provides evidence-based recommendations for diagnosis, treatment, chemoprophylaxis, and institutional outbreak management.

CDC Calls for Stepped-up Efforts against Carbapenem-resistant Bugs

The Centers for Disease Control and Prevention (CDC) is advising acute care facilities to take steps to control the spread of carbapenem-resistant Enterobacteriaceae (CRE) now, before these deadly and hard-to-treat pathogens become widespread.

Long-awaited FDA Guidance on CAP Drugs Released

A major barrier to new antibiotic development has come down: The Food and Drug Administration (FDA) has released long-awaited guidance for companies developing drugs for the therapy of community-acquired pneumonia (CAP).

IDSA Journal Club

This month: nephrotoxicity of adjunctive gentamicin; fluoroquinolone-resistant meningitis; declining MRSA CLABSIs; inactivated flu vaccine outperforms live-attenuated vaccine in healthy adults; multidrug-resistant gram-negatives on the rise; and possible new drugs for XDR TB.

Upcoming dates to remember

IDSA Membership Renewal
Renew your IDSA membership for 2009!

Society Awards application deadline
April 1, 2009 (5:00 p.m. EST)

Advancement to Fellow application deadline
April 1, 2009 (5:00 p.m. EST)

IDSA 47th Annual Meeting
October 29-November 1, 2009
Philadelphia, PA

Top Stories
New Influenza Guidelines Released
CDC Calls for Stepped-up Efforts against Carbapenem-resistant Bugs
Long-awaited FDA Guidance on CAP Drugs Released
IDSA Journal Club
Patient Care and Science
EIN: Better Testing for C. difficile
Drug Approvals, Recalls, Adverse Events Update
Practice Management
Medical Societies Raise Concerns About Medicare Audit Program
Global ID
New HIV/TB Figures Call for Increased Funding, ID Center Says
Policy and Advocacy
IDSA Responds to Supermarketsí Free Antibiotics Promotions
Forum Makes the Case for Medicare Coverage of Home Infusion Therapy
Deadline Extended for Public Input on Lyme Disease Guidelines
Your Colleagues
Welcome New IDSA Members!

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.

Unsubscribe here